These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
446 related articles for article (PubMed ID: 32799111)
1. The nucleosome remodeling and deacetylase complex has prognostic significance and associates with immune microenvironment in skin cutaneous melanoma. Liu X; Wang J Int Immunopharmacol; 2020 Nov; 88():106887. PubMed ID: 32799111 [TBL] [Abstract][Full Text] [Related]
2. Development and validation of an immune gene set-based prognostic signature in cutaneous melanoma. Tian Q; Gao H; Zhao W; Zhou Y; Yang J Future Oncol; 2021 Nov; 17(31):4115-4129. PubMed ID: 34291650 [TBL] [Abstract][Full Text] [Related]
3. Predicting the clinical outcome of melanoma using an immune-related gene pairs signature. Meng L; He X; Zhang X; Zhang X; Wei Y; Wu B; Li W; Li J; Xiao Y PLoS One; 2020; 15(10):e0240331. PubMed ID: 33031392 [TBL] [Abstract][Full Text] [Related]
4. Gene expression and immune infiltration in melanoma patients with different mutation burden. Wang L; Chen F; Liu R; Shi L; Zhao G; Yan Z BMC Cancer; 2021 Apr; 21(1):379. PubMed ID: 33836680 [TBL] [Abstract][Full Text] [Related]
5. Development of an IFNγ response-related signature for predicting the survival of cutaneous melanoma. Hu B; Wei Q; Li X; Ju M; Wang L; Zhou C; Chen L; Li Z; Wei M; He M; Zhao L Cancer Med; 2020 Nov; 9(21):8186-8201. PubMed ID: 32902917 [TBL] [Abstract][Full Text] [Related]
6. Analysis on tumor immune microenvironment and construction of a prognosis model for immune-related skin cutaneous melanoma. Wu M; Wang Z; Zhang J Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 May; 48(5):671-681. PubMed ID: 37539569 [TBL] [Abstract][Full Text] [Related]
7. Analysis of immune subtypes based on immunogenomic profiling identifies prognostic signature for cutaneous melanoma. Hu B; Wei Q; Zhou C; Ju M; Wang L; Chen L; Li Z; Wei M; He M; Zhao L Int Immunopharmacol; 2020 Dec; 89(Pt A):107162. PubMed ID: 33168410 [TBL] [Abstract][Full Text] [Related]
8. Data mining of immune-related prognostic genes in metastatic melanoma microenvironment. Han W; Huang B; Zhao XY; Shen GL Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33169786 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of the prognosis and biological significance for IFIT family in skin cutaneous melanoma. Jiang Y; Zhang C; Zhang J; Han D; Shi X Int Immunopharmacol; 2021 Dec; 101(Pt A):108344. PubMed ID: 34763233 [TBL] [Abstract][Full Text] [Related]
10. PMEL as a Prognostic Biomarker and Negatively Associated With Immune Infiltration in Skin Cutaneous Melanoma (SKCM). Zhang S; Chen K; Liu H; Jing C; Zhang X; Qu C; Yu S J Immunother; 2021 Jul-Aug 01; 44(6):214-223. PubMed ID: 34028390 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and immune-related value of STK17B in skin cutaneous melanoma. Shi X; Zhou Q; Huang B; Xia S; Jiang Y; Fang S; Lin J PLoS One; 2022; 17(2):e0263311. PubMed ID: 35171924 [TBL] [Abstract][Full Text] [Related]
12. A Necroptosis-Related Gene Signature to Predict the Prognosis of Skin Cutaneous Melanoma. Xie Y; Xu Z; Mei X; Shi W Dis Markers; 2022; 2022():8232024. PubMed ID: 36438905 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel disulfidptosis-related lncRNA signatures to predict the prognosis and immune microenvironment of skin cutaneous melanoma patients. Cheng S; Wang X; Yang S; Liang J; Song C; Zhu Q; Chen W; Ren Z; Zhu F Skin Res Technol; 2024 Jul; 30(7):e13814. PubMed ID: 38924611 [TBL] [Abstract][Full Text] [Related]
14. Development of a biomarker signature associated with anoikis to predict prognosis and immunotherapy response in melanoma. Wu Z; Zhang R; Bao J; Yin M; Wang X Arch Dermatol Res; 2024 May; 316(6):219. PubMed ID: 38787413 [TBL] [Abstract][Full Text] [Related]
15. Integrative lactylation and tumor microenvironment signature as prognostic and therapeutic biomarkers in skin cutaneous melanoma. Zhu Y; Song B; Yang Z; Peng Y; Cui Z; Chen L; Song B J Cancer Res Clin Oncol; 2023 Dec; 149(20):17897-17919. PubMed ID: 37955686 [TBL] [Abstract][Full Text] [Related]
16. Based on scRNA-seq and bulk RNA-seq to establish tumor immune microenvironment-associated signature of skin melanoma and predict immunotherapy response. Li S; Zhao J; Wang G; Yao Q; Leng Z; Liu Q; Jiang J; Wang W Arch Dermatol Res; 2024 May; 316(6):262. PubMed ID: 38795156 [TBL] [Abstract][Full Text] [Related]
17. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma. Song LB; Luan JC; Zhang QJ; Chen L; Wang HY; Cao XC; Song NH; Lu Y J Immunol Res; 2021; 2021():6686284. PubMed ID: 33688507 [TBL] [Abstract][Full Text] [Related]
18. Experimentally validated oxidative stress -associated prognostic signatures describe the immune landscape and predict the drug response and prognosis of SKCM. Rong D; Su Y; Jia D; Zeng Z; Yang Y; Wei D; Lu H; Cao Y Front Immunol; 2024; 15():1387316. PubMed ID: 38660305 [TBL] [Abstract][Full Text] [Related]
19. Identification of a novel tumour microenvironment-based prognostic biomarker in skin cutaneous melanoma. Yang RH; Liang B; Li JH; Pi XB; Yu K; Xiang SJ; Gu N; Chen XD; Zhou ST J Cell Mol Med; 2021 Dec; 25(23):10990-11001. PubMed ID: 34755462 [TBL] [Abstract][Full Text] [Related]
20. RARRES1 identified by comprehensive bioinformatic analysis and experimental validation as a promising biomarker in Skin Cutaneous Melanoma. Liu M; Bai R; Zhang G; Liu X; Wang Z; He K; Gan X; Zhou X; Yin P; Zheng Y; Wang G Sci Rep; 2024 Jun; 14(1):14113. PubMed ID: 38898266 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]